Report commissioned by govt analysed cost-effectiveness of 2 medicines, comparing them to to chemo in patients with newly ...

Frederick L. Locke, MD, discussed cema-cel's safety, efficacy, and potential for treating large B-cell lymphoma in earlier ...

In an effort to find new treatments for castrate-resistant prostate cancer, a TTUHSC research team led by Srinivas Nandana, ...

Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...

People with inflammatory bowel disease (IBD) also have an increased risk of developing colorectal cancer. However, the exact ...

After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, opening up the radioligand therapy to a much ...

Brain cancer remains one of medicine's most formidable challenges, requiring sophisticated treatment approaches tailored to ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a ...

IIT-G and Bose Institute develop advanced injectable hydrogel for precise cancer treatment, minimizing side effects on ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in pediatric ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...